Results 41 to 50 of about 12,085 (139)

The Repurposing of Non-Peptide Neurokinin-1 Receptor Antagonists as Antitumor Drugs: An Urgent Challenge for Aprepitant. [PDF]

Int J Mol Sci, 2023
Coveñas R, Rodríguez FD, Robinson P, Muñoz M.   +3 more
europepmc   +1 more source

Neurokinin-2 receptor negatively modulates substance P responses by forming complex with Neurokinin-1 receptor. [PDF]

Cell Biosci, 2023
Nguyen LP, Cho M, Nguyen TU, Park HK, Nguyen HT, Mykhailova K, Hurh S, Kim HR, Seong JY, Lee CS, Ham BJ, Hwang JI.   +11 more
europepmc   +1 more source

Substance P and Neurokinin-1 Receptor System in Thyroid Cancer: Potential Targets for New Molecular Therapies. [PDF]

J Clin Med, 2023
Isorna I, González-Moles MÁ, Muñoz M, Esteban F.   +3 more
europepmc   +1 more source

Therapeutic antagonism of the neurokinin 1 receptor in endosomes provides sustained pain relief. [PDF]

Proc Natl Acad Sci U S A, 2023
Hegron A, Peach CJ, Tonello R, Seemann P, Teng S, Latorre R, Huebner H, Weikert D, Rientjes J, Veldhuis NA, Poole DP, Jensen DD, Thomsen ARB, Schmidt BL, Imlach WL, Gmeiner P, Bunnett NW.   +16 more
europepmc   +1 more source

Recycling and Resensitization of the Neurokinin 1 Receptor [PDF]

Journal of Biological Chemistry, 2004
Dirk Roosterman, Graeme S. Cottrell, Fabien Schmidlin, Martin Steinhoff, Nigel W. Bunnett   +4 more
openaire   +1 more source

Prognostic Significance of Substance P and Neurokinin-1 Receptor in Bladder Cancer. [PDF]

Rep Biochem Mol Biol, 2022
Zahiri E, Ghorbani H, Moradi A, Mehrad-Majd H, Mohammadi F, Sharifi Sistani N, Hashemy SI.   +6 more
europepmc   +1 more source

Investigating genetic variants in microRNA regulators of Neurokinin-1 receptor in sudden infant death syndrome. [PDF]

Acta Paediatr, 2023
Shaukat Z, Byard RW, Vink R, Hussain R, Ricos MG, Dibbens LM.   +5 more
europepmc   +1 more source

Neurokinin-1 Receptor Antagonists as a Potential Novel Therapeutic Option for Osteosarcoma Patients. [PDF]

J Clin Med, 2023
Robinson P, Rosso M, Muñoz M.
europepmc   +1 more source

Involvement of the Substance P/Neurokinin-1 Receptor System in Cancer. [PDF]

Cancers (Basel), 2022
Coveñas R, Muñoz M.
europepmc   +1 more source

Neurokinin-1 receptor drives PKCɑ-AURKA/N-Myc signaling to facilitate the neuroendocrine progression of prostate cancer. [PDF]

Cell Death Dis, 2023
Zhang XW, Li JY, Li L, Hu WQ, Tao Y, Gao WY, Ye ZN, Jia HY, Wang JN, Miao XK, Yang WL, Wang R, Mou LY.   +12 more
europepmc   +1 more source